0001127602-13-017162.txt : 20130516 0001127602-13-017162.hdr.sgml : 20130516 20130516163824 ACCESSION NUMBER: 0001127602-13-017162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130514 FILED AS OF DATE: 20130516 DATE AS OF CHANGE: 20130516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGER HARVEY J M D CENTRAL INDEX KEY: 0000932052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 13851845 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-05-14 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0000932052 BERGER HARVEY J M D C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 1 Chairman & CEO Common Stock 2013-05-14 4 S 0 50000 18.0059 D 1553935 D Common Stock 2013-05-14 4 S 0 2700 18.00 D 19357 I Trust Common Stock 2013-05-15 4 S 0 37098 18.2212 D 1516837 D Common Stock 2013-05-15 4 S 0 2700 18.142 D 16657 I Trust Common Stock 246054 I Daughter Common Stock 248745 I Daughter Common Stock 1714286 I Ocean Capital Partners, Llc Common Stock 20251 I Wife This sale was effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.0000 to $18.0400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.02 to $18.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.09 to $18.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. The reporting person is a managing member of this LLC. /s/Edward M. Fitzgerald, Attorney-in-Fact 2013-05-16